Home › NDC Lookup › RxCUI directory › RxCUI 1043753

Azelaic acid 200 MG/ML Topical Cream [Azelex] — RxCUI 1043753

RxNorm drug concept · Semantic branded drug
RxCUI 1043753 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1043753
Official nameAzelaic acid 200 MG/ML Topical Cream [Azelex]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAzelex 20 % Topical Cream; Azelex 200 MG/ML Topical Cream
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Azelaic Acid Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Azelaic acid gel, 15% treats the red bumps and pimples of mild to moderate rosacea. It has not been studied for redness alone, without bumps and pimples.
  • It goes on your skin only. For FINACEA Foam, shake it, wash your face with a very mild cleanser, pat dry, and apply a thin layer to your whole face morning and evening. Wash your h...
  • Yes, burning, stinging, itching and dryness are the most common effects, usually in the first few weeks. If irritation becomes severe or doesn't go away, stop and call your doctor.
  • Get help for swelling of your face or eyes, hives or trouble breathing, since these can be signs of an allergic reaction. Also call your doctor if your asthma gets worse.
📖 Read our full Azelaic Acid Topical guide →

🕸️ Concept Web — How Azelaic acid 200 MG/ML Topical Cream [Azelex] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Azelaic acid 200 MG/ML Topical Cream [Azelex] RxCUI 1043753

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Azelate 618278
    • Azelaic acid 18602
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Azelex 215499
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Azelate Topical Cream 618280
    • Azelaic acid Topical Cream 2648774
    • Azelate Topical Product 1155005
    • Azelaic acid Topical Product 2662121
    • Azelate Topical Cream [Azelex] 632300
    • Azelaic acid Topical Cream [Azelex] 2657671
    • Azelex Topical Product 1176322
    • Topical Cream 316982
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Azelaic acid 200 MG/ML Topical Cream SCD · 1041520
  • Azelaic acid 200 MG/ML SCDC · 1041519
  • Azelate Topical Cream SCDF · 618280
  • Azelaic acid Topical Cream SCDFP · 2648774
  • Azelate Topical Product SCDG · 1155005
  • Azelaic acid Topical Product SCDGP · 2662121

Brand-Name Concepts

  • Azelaic acid 200 MG/ML [Azelex] SBDC · 1043752
  • Azelate Topical Cream [Azelex] SBDF · 632300
  • Azelaic acid Topical Cream [Azelex] SBDFP · 2657671
  • Azelex Topical Product SBDG · 1176322
  • Azelex BN · 215499

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1043753 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
16110-0869-30 1 TUBE in 1 CARTON (16110-869-30) / 30 g in 1 TUBE AZELEX Almirall, LLC 2019-07-12
16110-0869-50 1 TUBE in 1 CARTON (16110-869-50) / 50 g in 1 TUBE AZELEX Almirall, LLC 2019-07-12
Observed labelers: Almirall, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.